世界のモノクローナル抗体治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Monoclonal Antibody Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z09556 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、モノクローナル抗体治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。モノクローナル抗体治療の種類別市場規模（がん、自己免疫疾患、感染症、造血系疾患、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・モノクローナル抗体治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Bayer、Sanofi、Merck、GlaxoSmithKline、Roche、Novartis、AbbVie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：がん、自己免疫疾患、感染症、造血系疾患、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・モノクローナル抗体治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・モノクローナル抗体治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・モノクローナル抗体治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・モノクローナル抗体治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・モノクローナル抗体治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Monoclonal Antibody Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Monoclonal Antibody Treatment size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Monoclonal Antibody Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Monoclonal Antibody Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Treatment
1.2 Classification of Monoclonal Antibody Treatment by Type
1.2.1 Overview: Global Monoclonal Antibody Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Monoclonal Antibody Treatment Revenue Market Share by Type in 2020
1.2.3 Cancer
1.2.4 Autoimmune Diseases
1.2.5 Infection
1.2.6 Hematological Diseases
1.2.7 Others
1.3 Global Monoclonal Antibody Treatment Market by Application
1.3.1 Overview: Global Monoclonal Antibody Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Monoclonal Antibody Treatment Market Size & Forecast
1.5 Global Monoclonal Antibody Treatment Market Size and Forecast by Region
1.5.1 Global Monoclonal Antibody Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Monoclonal Antibody Treatment Market Size by Region, (2016-2021)
1.5.3 North America Monoclonal Antibody Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Monoclonal Antibody Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Monoclonal Antibody Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Monoclonal Antibody Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Monoclonal Antibody Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibody Treatment Market Drivers
1.6.2 Monoclonal Antibody Treatment Market Restraints
1.6.3 Monoclonal Antibody Treatment Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Monoclonal Antibody Treatment Product and Solutions
2.1.4 Pfizer Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Monoclonal Antibody Treatment Product and Solutions
2.2.4 Bayer Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bayer Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Monoclonal Antibody Treatment Product and Solutions
2.3.4 Sanofi Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Monoclonal Antibody Treatment Product and Solutions
2.4.4 Merck Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Product and Solutions
2.5.4 GlaxoSmithKline Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Monoclonal Antibody Treatment Product and Solutions
2.6.4 Roche Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Monoclonal Antibody Treatment Product and Solutions
2.7.4 Novartis Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Monoclonal Antibody Treatment Product and Solutions
2.8.4 AbbVie Monoclonal Antibody Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AbbVie Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Monoclonal Antibody Treatment Players Market Share
3.2.2 Top 10 Monoclonal Antibody Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Monoclonal Antibody Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Monoclonal Antibody Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Monoclonal Antibody Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Monoclonal Antibody Treatment Revenue Market Share by Application (2016-2021)
5.2 Monoclonal Antibody Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Monoclonal Antibody Treatment Revenue by Type (2016-2026)
6.2 North America Monoclonal Antibody Treatment Revenue by Application (2016-2026)
6.3 North America Monoclonal Antibody Treatment Market Size by Country
6.3.1 North America Monoclonal Antibody Treatment Revenue by Country (2016-2026)
6.3.2 United States Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Monoclonal Antibody Treatment Revenue by Type (2016-2026)
7.2 Europe Monoclonal Antibody Treatment Revenue by Application (2016-2026)
7.3 Europe Monoclonal Antibody Treatment Market Size by Country
7.3.1 Europe Monoclonal Antibody Treatment Revenue by Country (2016-2026)
7.3.2 Germany Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
7.3.3 France Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region
8.3.1 Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2016-2026)
8.3.2 China Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8.3.5 India Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Monoclonal Antibody Treatment Revenue by Type (2016-2026)
9.2 South America Monoclonal Antibody Treatment Revenue by Application (2016-2026)
9.3 South America Monoclonal Antibody Treatment Market Size by Country
9.3.1 South America Monoclonal Antibody Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country
10.3.1 Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Monoclonal Antibody Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Monoclonal Antibody Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Monoclonal Antibody Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Monoclonal Antibody Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Monoclonal Antibody Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Monoclonal Antibody Treatment Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Monoclonal Antibody Treatment Product and Solutions
Table 9. Pfizer Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bayer Corporate Information, Head Office, and Major Competitors
Table 11. Bayer Major Business
Table 12. Bayer Monoclonal Antibody Treatment Product and Solutions
Table 13. Bayer Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Monoclonal Antibody Treatment Product and Solutions
Table 17. Sanofi Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Monoclonal Antibody Treatment Product and Solutions
Table 21. Merck Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Monoclonal Antibody Treatment Product and Solutions
Table 25. GlaxoSmithKline Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Monoclonal Antibody Treatment Product and Solutions
Table 29. Roche Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Monoclonal Antibody Treatment Product and Solutions
Table 33. Novartis Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AbbVie Corporate Information, Head Office, and Major Competitors
Table 35. AbbVie Major Business
Table 36. AbbVie Monoclonal Antibody Treatment Product and Solutions
Table 37. AbbVie Monoclonal Antibody Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Monoclonal Antibody Treatment Revenue (USD Million) by Players (2019-2021)
Table 39. Global Monoclonal Antibody Treatment Revenue Share by Players (2019-2021)
Table 40. Breakdown of Monoclonal Antibody Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Monoclonal Antibody Treatment Players Head Office, Products and Services Provided
Table 42. Monoclonal Antibody Treatment Mergers & Acquisitions in the Past Five Years
Table 43. Monoclonal Antibody Treatment New Entrants and Expansion Plans
Table 44. Global Monoclonal Antibody Treatment Revenue (USD Million) by Type (2016-2021)
Table 45. Global Monoclonal Antibody Treatment Revenue Share by Type (2016-2021)
Table 46. Global Monoclonal Antibody Treatment Revenue Forecast by Type (2021-2026)
Table 47. Global Monoclonal Antibody Treatment Revenue by Application (2016-2021)
Table 48. Global Monoclonal Antibody Treatment Revenue Forecast by Application (2021-2026)
Table 49. North America Monoclonal Antibody Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Monoclonal Antibody Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Monoclonal Antibody Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Monoclonal Antibody Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Monoclonal Antibody Treatment Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Monoclonal Antibody Treatment Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Monoclonal Antibody Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Monoclonal Antibody Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Monoclonal Antibody Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Monoclonal Antibody Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Monoclonal Antibody Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Monoclonal Antibody Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Monoclonal Antibody Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Monoclonal Antibody Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Monoclonal Antibody Treatment Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Monoclonal Antibody Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Monoclonal Antibody Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Monoclonal Antibody Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Monoclonal Antibody Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Monoclonal Antibody Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Monoclonal Antibody Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Monoclonal Antibody Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Monoclonal Antibody Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Monoclonal Antibody Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Monoclonal Antibody Treatment Picture
Figure 2. Global Monoclonal Antibody Treatment Revenue Market Share by Type in 2020
Figure 3. Cancer
Figure 4. Autoimmune Diseases
Figure 5. Infection
Figure 6. Hematological Diseases
Figure 7. Others
Figure 8. Monoclonal Antibody Treatment Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Monoclonal Antibody Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Monoclonal Antibody Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Monoclonal Antibody Treatment Revenue Market Share by Region (2016-2026)
Figure 15. Global Monoclonal Antibody Treatment Revenue Market Share by Region in 2020
Figure 16. North America Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Monoclonal Antibody Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Monoclonal Antibody Treatment Market Drivers
Figure 21. Monoclonal Antibody Treatment Market Restraints
Figure 22. Monoclonal Antibody Treatment Market Trends
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. AbbVie Recent Developments and Future Plans
Figure 32. Global Monoclonal Antibody Treatment Revenue Share by Players in 2020
Figure 33. Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Monoclonal Antibody Treatment Revenue Market Share in 2020
Figure 35. Global Top 10 Players Monoclonal Antibody Treatment Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Monoclonal Antibody Treatment Revenue Share by Type in 2020
Figure 38. Global Monoclonal Antibody Treatment Market Share Forecast by Type (2021-2026)
Figure 39. Global Monoclonal Antibody Treatment Revenue Share by Application in 2020
Figure 40. Global Monoclonal Antibody Treatment Market Share Forecast by Application (2021-2026)
Figure 41. North America Monoclonal Antibody Treatment Sales Market Share by Type (2016-2026)
Figure 42. North America Monoclonal Antibody Treatment Sales Market Share by Application (2016-2026)
Figure 43. North America Monoclonal Antibody Treatment Revenue Market Share by Country (2016-2026)
Figure 44. United States Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Monoclonal Antibody Treatment Sales Market Share by Type (2016-2026)
Figure 48. Europe Monoclonal Antibody Treatment Sales Market Share by Application (2016-2026)
Figure 49. Europe Monoclonal Antibody Treatment Revenue Market Share by Country (2016-2026)
Figure 50. Germany Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Monoclonal Antibody Treatment Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Monoclonal Antibody Treatment Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Monoclonal Antibody Treatment Revenue Market Share by Region (2016-2026)
Figure 58. China Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Monoclonal Antibody Treatment Sales Market Share by Type (2016-2026)
Figure 65. South America Monoclonal Antibody Treatment Sales Market Share by Application (2016-2026)
Figure 66. South America Monoclonal Antibody Treatment Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Monoclonal Antibody Treatment Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Monoclonal Antibody Treatment Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Monoclonal Antibody Treatment Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Monoclonal Antibody Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---